Respiratory Complications in Patients with Hyper IgM Syndrome

Purpose Hyper Immunoglobulin M (HIgM) syndrome is a heterogeneous group of primary immunodeficiency disorders, characterized by recurrent infections and associated with decreased serum IgG and IgA, but normal or increased IgM . The aim of the present study was to evaluate respiratory manifestations...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical immunology Vol. 39; no. 6; pp. 557 - 568
Main Authors Moazzami, Bobak, Yazdani, Reza, Azizi, Gholamreza, Kiaei, Fatemeh, Tafakori, Mitra, Modaresi, Mohammadreza, Shirzadi, Rohola, Mahdaviani, Seyed Alireza, Sohani, Mahsa, Abolhassani, Hassan, Aghamohammadi, Asghar
Format Journal Article
LanguageEnglish
Published New York Springer US 01.08.2019
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Purpose Hyper Immunoglobulin M (HIgM) syndrome is a heterogeneous group of primary immunodeficiency disorders, characterized by recurrent infections and associated with decreased serum IgG and IgA, but normal or increased IgM . The aim of the present study was to evaluate respiratory manifestations in patients with HIgM syndrome. Methods A total number of 62 patients, including 46 males and 16 females were included in the present study. To investigate the respiratory complications among HIgM patients, we evaluated the clinical hospital records, immunologic and molecular diagnostic assays, pulmonary function tests (PFT), and high-resolution computed tomography (HRCT) scans. Results Pneumonia was the most common respiratory manifestation ( n  = 35, 56.4%), followed by otitis media (45.1%), sinusitis (33.8%), and bronchiectasis (14.5%). 52.1% of the patients had abnormal PFT results, with a predominant restrictive pattern of changes. HRCT scans demonstrated abnormal findings in 85.7% of patients with found mutations. Ten cases had hilar lymphadenopathy and para-hilar infiltrates in their HRCT findings. Genetic diagnosis was confirmed in 29 HIgM patients (72.4% CD40 ligand (CD40L) and 24.1% activation-induced cytidine deaminase (AICDA/AID) deficiencies). Majority of patients with CD40L (71.4%) and AID (57.1%) deficiencies had missense mutations. Pneumonia and abnormal high-resolution computed tomography (HRCT) findings were more frequent among patients with CD40L mutation. Respiratory failure constituted the major cause of mortality (37.5%) with majority of cases occurring in CD40L-deficient patients (50%). Conclusions Respiratory complications are common in patients with HIgM syndrome. A proper awareness of respiratory manifestations in patients with HIgM may result in improved management, reduced morbidity and mortality, and an improvement in the quality of life of the patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0271-9142
1573-2592
1573-2592
DOI:10.1007/s10875-019-00650-3